SJS Investment Consulting Inc.

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1894302 SYLVANIA, OH

Position in BMRN

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$50,181

+$10,356 QoQ

Shares Held

877

+24.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#453

of 565 holders

Holding Since

Mar 2022

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

SJS Investment Consulting Inc. holds $1,414,824 across 170 Biotechnology names. BMRN ranks #4 (3.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SLS	SELLAS Life Sciences Group, Inc.	40,000	$590,400
2	JAZZ	Jazz Pharmaceuticals plc	840	$202,414
3	TNXP	Tonix Pharmaceuticals Holding Corp.	10,204	$130,203
4	BMRN	Biomarin Pharmaceutical Inc This page	877	$50,181
5	EXEL	Exelixis, Inc.	821	$44,670
6	VRTX	Vertex Pharmaceuticals Inc / Ma	59	$29,306
7	REGN	Regeneron Pharmaceuticals, Inc.	47	$29,305
8	INCY	Incyte Corp	208	$23,578

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$50,181	877	+24.4%	Shares	Defined	2026-07-22
2026-03-31	$39,825	705	+21.8%	Shares	Defined	2026-04-23
2025-12-31	$34,409	579	+4353.8%	Shares	Sole	2026-01-21
2025-09-30	$704	13	-38.1%	Shares	Defined	2025-10-21
2025-03-31	$1,484	21	+425.0%	Shares	Defined	2025-04-15
2024-12-31	$262	4	-85.7%	Shares	Defined	2025-01-21
2024-09-30	$1,968	28	+55.6%	Shares	Defined	2024-10-16
2024-06-30	$1,481	18	-5.3%	Shares	Defined	2024-07-16
2024-03-31	$1,659	19	+18.8%	Shares	Defined	2024-04-18
2023-12-31	$1,542	16	-27.3%	Shares	Defined	2024-01-16
2023-09-30	$1,946	22	+10.0%	Shares	Defined	2023-10-17
2023-06-30	$1,733	20	+42.9%	Shares	Defined	2023-07-13
2023-03-31	$1,361	14	-39.1%	Shares	Defined	2023-04-20
2022-12-31	$2,380	23	+76.9%	Shares	Defined	2023-01-23
2022-09-30	$1,102	13	+333.3%	Shares	Defined	2022-10-13
2022-03-31	$231	3	—	Shares	Sole	2022-05-05
No filing history on record for this holder in this stock.